351 related articles for article (PubMed ID: 19373675)
1. RPE65: role in the visual cycle, human retinal disease, and gene therapy.
Cai X; Conley SM; Naash MI
Ophthalmic Genet; 2009 Jun; 30(2):57-62. PubMed ID: 19373675
[TBL] [Abstract][Full Text] [Related]
2. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
[TBL] [Abstract][Full Text] [Related]
3. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
[TBL] [Abstract][Full Text] [Related]
4. In utero gene therapy rescues vision in a murine model of congenital blindness.
Dejneka NS; Surace EM; Aleman TS; Cideciyan AV; Lyubarsky A; Savchenko A; Redmond TM; Tang W; Wei Z; Rex TS; Glover E; Maguire AM; Pugh EN; Jacobson SG; Bennett J
Mol Ther; 2004 Feb; 9(2):182-8. PubMed ID: 14759802
[TBL] [Abstract][Full Text] [Related]
5. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
[TBL] [Abstract][Full Text] [Related]
6. Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.
Pang J; Boye SE; Lei B; Boye SL; Everhart D; Ryals R; Umino Y; Rohrer B; Alexander J; Li J; Dai X; Li Q; Chang B; Barlow R; Hauswirth WW
Gene Ther; 2010 Jul; 17(7):815-26. PubMed ID: 20237510
[TBL] [Abstract][Full Text] [Related]
7. Bax-induced apoptosis in Leber's congenital amaurosis: a dual role in rod and cone degeneration.
Hamann S; Schorderet DF; Cottet S
PLoS One; 2009 Aug; 4(8):e6616. PubMed ID: 19672311
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of gene transfer for Leber's congenital amaurosis.
Maguire AM; Simonelli F; Pierce EA; Pugh EN; Mingozzi F; Bennicelli J; Banfi S; Marshall KA; Testa F; Surace EM; Rossi S; Lyubarsky A; Arruda VR; Konkle B; Stone E; Sun J; Jacobs J; Dell'Osso L; Hertle R; Ma JX; Redmond TM; Zhu X; Hauck B; Zelenaia O; Shindler KS; Maguire MG; Wright JF; Volpe NJ; McDonnell JW; Auricchio A; High KA; Bennett J
N Engl J Med; 2008 May; 358(21):2240-8. PubMed ID: 18441370
[TBL] [Abstract][Full Text] [Related]
9. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
[TBL] [Abstract][Full Text] [Related]
10. Impacts of two point mutations of RPE65 from Leber's congenital amaurosis on the stability, subcellular localization and isomerohydrolase activity of RPE65.
Chen Y; Moiseyev G; Takahashi Y; Ma JX
FEBS Lett; 2006 Jul; 580(17):4200-4. PubMed ID: 16828753
[TBL] [Abstract][Full Text] [Related]
11. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.
Cideciyan AV; Aleman TS; Boye SL; Schwartz SB; Kaushal S; Roman AJ; Pang JJ; Sumaroka A; Windsor EA; Wilson JM; Flotte TR; Fishman GA; Heon E; Stone EM; Byrne BJ; Jacobson SG; Hauswirth WW
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15112-7. PubMed ID: 18809924
[TBL] [Abstract][Full Text] [Related]
12. Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.
Redmond TM; Poliakov E; Yu S; Tsai JY; Lu Z; Gentleman S
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13658-63. PubMed ID: 16150724
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy restores vision in a canine model of childhood blindness.
Acland GM; Aguirre GD; Ray J; Zhang Q; Aleman TS; Cideciyan AV; Pearce-Kelling SE; Anand V; Zeng Y; Maguire AM; Jacobson SG; Hauswirth WW; Bennett J
Nat Genet; 2001 May; 28(1):92-5. PubMed ID: 11326284
[TBL] [Abstract][Full Text] [Related]
14. Rpe65-/- and Lrat-/- mice: comparable models of leber congenital amaurosis.
Fan J; Rohrer B; Frederick JM; Baehr W; Crouch RK
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2384-9. PubMed ID: 18296659
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
[TBL] [Abstract][Full Text] [Related]
16. Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).
Pang JJ; Chang B; Hawes NL; Hurd RE; Davisson MT; Li J; Noorwez SM; Malhotra R; McDowell JH; Kaushal S; Hauswirth WW; Nusinowitz S; Thompson DA; Heckenlively JR
Mol Vis; 2005 Feb; 11():152-62. PubMed ID: 15765048
[TBL] [Abstract][Full Text] [Related]
17. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635
[TBL] [Abstract][Full Text] [Related]
18. Biological characterization of gene response in Rpe65-/- mouse model of Leber's congenital amaurosis during progression of the disease.
Cottet S; Michaut L; Boisset G; Schlecht U; Gehring W; Schorderet DF
FASEB J; 2006 Oct; 20(12):2036-49. PubMed ID: 17012256
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular genetics of Leber's congenital amaurosis: a multicenter study of Italian patients.
Simonelli F; Ziviello C; Testa F; Rossi S; Fazzi E; Bianchi PE; Fossarello M; Signorini S; Bertone C; Galantuomo S; Brancati F; Valente EM; Ciccodicola A; Rinaldi E; Auricchio A; Banfi S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4284-90. PubMed ID: 17724218
[TBL] [Abstract][Full Text] [Related]
20. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
